These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16570910)

  • 41. Metallic nanoparticles bioassay for Enterobacter cloacae P99 beta-lactamase activity and inhibitor screening.
    Liu R; Teo W; Tan S; Feng H; Padmanabhan P; Xing B
    Analyst; 2010 May; 135(5):1031-6. PubMed ID: 20419253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A sensitive coupled HPLC/electrospray mass spectrometry assay for SPM-1 metallo-beta-lactamase inhibitors.
    Sanchez PA; Toney JH; Thomas JD; Berger JM
    Assay Drug Dev Technol; 2009 Apr; 7(2):170-9. PubMed ID: 19505232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel combinations of antibiotics to inhibit extended-spectrum β-lactamase and metallo-β-lactamase producers in vitro: a synergistic approach.
    Hasan S; Ali SZ; Khan AU
    Future Microbiol; 2013 Jul; 8(7):939-44. PubMed ID: 23841638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iatrogenic disorders.
    Moser RH
    Mil Med; 1970 Aug; 135(8):619-30. PubMed ID: 4991302
    [No Abstract]   [Full Text] [Related]  

  • 45. Synergy and antagonism are not synonymous with therapeutic advantage and disadvantage.
    Berenbaum MC
    J Antimicrob Chemother; 1988 Apr; 21(4):497-500. PubMed ID: 3378962
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug synergy scoring using minimal dose response matrices.
    Mäkelä P; Zhang SM; Rudd SG
    BMC Res Notes; 2021 Jan; 14(1):27. PubMed ID: 33468238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative proteomics approach for identifying protein-drug interactions in complex mixtures using protein stability measurements.
    West GM; Tucker CL; Xu T; Park SK; Han X; Yates JR; Fitzgerald MC
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9078-82. PubMed ID: 20439767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-response analysis of combination preparations.
    Unkelbach HD; Wolf T
    Stat Med; 1985; 4(1):77-85. PubMed ID: 3992075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of drug interactions.
    Hussar DA
    J Am Pharm Assoc; 1969 May; 9(5):208-9 passim. PubMed ID: 5783565
    [No Abstract]   [Full Text] [Related]  

  • 50. [Porbabilistic interpretation of drug antagonism and synergism].
    SEGRE G
    Arch Int Pharmacodyn Ther; 1956 Feb; 105(1-2):230-40. PubMed ID: 13314732
    [No Abstract]   [Full Text] [Related]  

  • 51. Synergy Maps: exploring compound combinations using network-based visualization.
    Lewis R; Guha R; Korcsmaros T; Bender A
    J Cheminform; 2015; 7():36. PubMed ID: 26236402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An analysis of functional antagonism and synergism.
    Mackay D
    Br J Pharmacol; 1981 May; 73(1):127-34. PubMed ID: 7284692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The problem of synergism and antagonism of combined drugs.
    LOEWE S
    Arzneimittelforschung; 1953 Jun; 3(6):285-90. PubMed ID: 13081480
    [No Abstract]   [Full Text] [Related]  

  • 54. Elucidation of conformational diversity of druggable enzymes and classification of chemical modulators based on inhibitor-bound structures.
    Akula S; Vanamamalai VK; Nair Ru VP; Vudem DR; Kancha RK
    J Biomol Struct Dyn; 2019 Oct; 37(17):4563-4568. PubMed ID: 30488775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The measure of synergy in enzymatic regulation. A general coefficient.
    Mazat F; Langla J; Mazat JP
    Biochimie; 1981 Feb; 63(2):107-11. PubMed ID: 7225458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacodynamic study of the conjoint action of different substances; antagonism and synergy].
    QUIVY D; BERTRAND I; GAYET-HALLION T
    Ann Pharm Fr; 1950 Mar; 8(3):217-25. PubMed ID: 15419560
    [No Abstract]   [Full Text] [Related]  

  • 57. Synergism and inhibition of drug resistance.
    KLEIN M; KIMMELMAN LJ
    J Bacteriol; 1947 Jul; 54(1):8. PubMed ID: 20344228
    [No Abstract]   [Full Text] [Related]  

  • 58. The estimation of synergy or antagonism.
    Rothman KJ
    Am J Epidemiol; 1976 May; 103(5):506-11. PubMed ID: 1274952
    [No Abstract]   [Full Text] [Related]  

  • 59. [Contributions to the knowledge of the shaking brushes and their stabilization].
    MUEHLEMANN H; SAGER H
    Pharm Acta Helv; 1946 Jun; 21(5-6):83-111. PubMed ID: 20277031
    [No Abstract]   [Full Text] [Related]  

  • 60. Editorial for Special Issue on Chemical Complexity and Biology.
    Delsuc MA; Kieffer B
    Biophys Chem; 2016 Mar; 210():1. PubMed ID: 26899865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.